Swiss drugmaker, Novartis and Google Inc. have signed an agreement to develop ‘smart’ contact lenses that would help diabetics to track their blood glucose levels or restore the eye’s ability to focus, Reuters has reported. The device for diabetics would measure glucose in tear fluid and send the data wirelessly to a mobile device, Novartis said. The second element of the Google agreement focuses on presbyopia, in which ageing eyes have trouble focusing on close objects. Novartis hopes the lens technology will help to restore the eye’s ability to focus, almost like the autofocus on a camera.
Thursday, July 17- 2014 @ 0:03 UAE local time (GMT+4) Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of Mediaquest FZ LLC.